Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Sanofi Sarclisa approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant

Ruchika Sharma2 Feb 2025 10:45 AM IST

Paris: Sanofi has announced that the National Medical Products Administration (NMPA) in China has approved Sarclisa, in combination with a...

Sun Pharmas Dapagliflozin, Glimepiride, Metformin FDC Fails to Secure CDSCO Panel Nod Over Safety, Utility Concerns

Sun Pharma net profit rises 15 percent to Rs 2903 crore in Q3

Ruchika Sharma1 Feb 2025 3:30 PM IST

New Delhi: Sun Pharmaceutical Industries reported a 15 percent on-year increase in consolidated net profit, reaching Rs 2,903 crore for the December...

Biocon likely to list key biosimilars business by March 2026

Ruchika Sharma1 Feb 2025 2:30 PM IST

Hyderabad: Biopharma major Biocon plans to introduce five new biosimilars in the United States in the new fiscal year, starting in April and is likely...

Roche bags USFDA nod for companion diagnostic to identify patients with HER2-ultralow metastatic breast cancer eligible for Enhertu

Ruchika Sharma1 Feb 2025 12:30 PM IST

Basel: Roche has announced that the U.S. Food and Drug Administration (FDA) has approved a label expansion for the PATHWAY anti-HER2/neu (4B5)...

Aurobindo Pharma restarts production at Kakinada Penicillin-G plant after fire incident

Aurobindo Pharma arm gets positive opinion for biosimilar Dyrupeg from EMA

Ruchika Sharma1 Feb 2025 11:30 AM IST

Hyderabad: CuraTeQ Biologics s.r.o., a step-down subsidiary of Aurobindo Pharma Limited, has announced that the Committee for Medicinal...

Supreme Court Issues notice to NMC on Delay in Compulsory Rotating Internship for FMGs

SC quashes proceedings against two medical firms, faults summoning orders

Ruchika Sharma31 Jan 2025 5:37 PM IST

New Delhi: The proceedings against two medical companies accused of violating provisions of the Drugs and Cosmetics Act have been quashed by the...

Roche appoints Wafaa Mamilli as Chief Digital Technology Officer

Roche names Wafaa Mamilli as Chief Digital Technology Officer

Ruchika Sharma31 Jan 2025 1:30 PM IST

Basel: Roche has announced that Wafaa Mamilli will join the company as Chief Digital Technology Officer (CDTO), reporting to Group CEO, Thomas...

Merck, Daiichi Sankyo Ifinatamab deruxtecan granted Breakthrough Therapy Designation by USFDA for pretreated extensive-stage small cell lung cancer

Merck to stop trial evaluating Winrevair early in pulmonary arterial hypertension

Ruchika Sharma31 Jan 2025 12:30 PM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the Phase 3 HYPERION study evaluating WINREVAIR...

DCGI nod to Bajaj Healthcare for manufacturing Parkinson's disease psychosis drug Pimavanserin in India

Ruchika Sharma31 Jan 2025 11:30 AM IST

Mumbai: Bajaj Healthcare Limited has announced that it has received approval from the Drug Controller General of India (DCGI) to manufacture both...

Julie Kim to succeed Christophe Weber as CEO of Takeda

Ruchika Sharma30 Jan 2025 5:06 PM IST

Osaka: Takeda has announced that its Board of Directors made the decision unanimously to appoint Julie Kim, currently president of Takeda's...

Roche Pharma India appoints Rajwinder (Rajji) Mehdwan as new Country General Manager

Ruchika Sharma30 Jan 2025 3:05 PM IST

Mumbai: Roche Pharma India has announced the appointment of Rajwinder (Rajji) Mehdwan as country General Manager, effective 1...

Delhi Police Cracks Fake Drug Network, Counterfeit Ultracet, Augmentin Seized, 6 Held

Granules India arm gets USFDA nod for ADHD drug Lisdexamfetamine Dimesylate

Ruchika Sharma30 Jan 2025 2:30 PM IST

Hyderabad: Granules India Limited, a vertically integrated Indian pharmaceutical company, has announced that its wholly-owned foreign...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok